A Research Study Looking at a Single Dose of Etavopivat in Healthy Chinese Participants

NCT06581627 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers
Sickle Cell Disease
Thalassemia

Interventions

DRUG: Etavopivat

Sponsor

Novo Nordisk A/S